TY  - JOUR
AU  - Mondejar-Lopez, Pedro
AU  - Quintana-Gallego, Esther
AU  - Giron-Moreno, Rosa M
AU  - Cortell-Aznar, Isidoro
AU  - Ruiz-de-Valbuena-Maiz, Marta
AU  - Diab-Caceres, Layla
AU  - Prados-Sanchez, Concepcion
AU  - Alvarez-Fernandez, Antonio
AU  - Garcia-Marcos, Patricia W
AU  - Peñalver-Mellado, Carlos
AU  - Pastor-Vivero, M Dolores
AU  - Olveira, Casilda
AU  - Lopez-Neyra, Alejandro
AU  - Castillo-Corullon, Silvia
AU  - Palma-Milla, Samara
AU  - Perez-Ruiz, Estela
AU  - Sole-Jover, Amparo
AU  - Barrio, M Isabel
AU  - Sanchez-Solis, Manuel
AU  - Asensio-de-la-Cruz, Oscar
PY  - 2020
DO  - 10.1016/j.rmed.2020.106062
UR  - http://hdl.handle.net/10668/16152
T2  - Respiratory medicine
AB  - Given the high incidence of confirmed infection by SARS-CoV-2 and mortality by COVID-19 in the Spanish population, its impact was analysed among persons with Cystic Fibrosis (CF) as a group at risk of a worse evolution. The possible causes of the...
LA  - en
KW  - COVID-19
KW  - Coronavirus
KW  - Cystic fibrosis
KW  - SARS-CoV-2
KW  - Adult
KW  - Betacoronavirus
KW  - COVID-19
KW  - COVID-19 Testing
KW  - Clinical Laboratory Techniques
KW  - Coronavirus Infections
KW  - Cystic Fibrosis
KW  - Female
KW  - Humans
KW  - Incidence
KW  - Male
KW  - Mortality
KW  - Pandemics
KW  - Pneumonia, Viral
KW  - Registries
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - SARS-CoV-2
KW  - Spain
TI  - Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey.
TY  - research article
VL  - 170
ER  -